Sakuranetin Prevents Acetaminophen-Induced Liver Injury via Nrf2-Induced Inhibition of Hepatocyte Ferroptosis
Sakuranetin alleviates AILI by activating the Nrf2 signaling pathway and inhibiting ferroptosis, and sakuranetin may be a potential therapeutic agent for the treatment of AILI.
Authors
- Zhi‐Da Long
- Nuo Cheng (ORCID: https://orcid.org/0000-0002-2614-8682)
- Chenglong Huo
- Xiao Yu (ORCID: https://orcid.org/0000-0001-5310-205X)
- Shuai Wang (ORCID: https://orcid.org/0000-0003-0718-1820)
- Xuewen Zhang (ORCID: https://orcid.org/0000-0003-2553-2815)
- Shijia Li (ORCID: https://orcid.org/0000-0002-4937-8819)
Institutions
- Yangtze University (CN)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2025-01-01
- DOI
- https://doi.org/10.2147/dddt.s497817
- Citations
- 16
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 21.67
Funders
- Natural Science Foundation of Hubei Province